Articles

In a randomized controlled trial researchers also looked at pregnancy and the risk for GDM-related adverse effects….

Procalcitonin, a 116-amino acid peptide of calcitonin, is a new diagnostic marker of bacterial infections…. 

Intensification of therapy for patients with type 2 diabetes who have suboptimal glucose control is often delayed….

Nonaneurysmal subarachnoid hemorrhage (SAH) appears to be a distinct microvascular complication of type 1 diabetes….

The FDA has acknowledged receipt of a resubmission of the new drug application (NDA) for dapagliflozin, an SGLT-2 inhibitor for the treatment of type 2 diabetes…. Astra Zeneca and Bristol-Myers Squibb (BMS) have announced that the agency has issued a new Prescription Drug User Fee Act goal date of January …

‘Reprogrammed’ glucose uptake in the small intestine may explain why gastric bypass surgery can sometimes result in the early resolution of type 2 diabetes…. 

Skipping breakfast or eating late at night should top the not-to-do lists of men in middle age and beyond; not only do they have metabolic effects, they may also put men at higher risk for coronary heart disease…. 

Researchers just reported that skipping breakfast was linked to heart disease (see this week’s Item #5) but a few days later comes word that skipping breakfast could be a good weight-loss strategy because people don’t make up for all those calories later in the day…. 

According to the European Medicines Agency’s Committee for Medicinal Products for Human Use, current data linking glucagon-like-peptide-1 (GLP-1) agonists to adverse pancreatic events are not adequate….

A registry study affirmed that insulin glargine (Lantus) didn’t significantly raise cancer risk compared with "human" insulin….